IS RIBAVIRIN ACTUALLY USEFUL FOR GENOTYPE 1 (G1) CIRRHOTIC PATIENTS WHO RECEIVE DAAS COMBINATION ? A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (RCTS)
Vincent Di Martino 1
Carine Richou 1
Jean-Paul Cervoni 1
Delphine Weil-Verhoven 1
Claire Vanlemmens 1
Thong Dao 2
Yannick Bacq 3
Anne Minello 4
Véronique Loustaud-Ratti
Odile Goria
Thierry Thévenot
1 service d'hépatologie,CHU Jean Minjoz,Besançon,France
2 CHU Caen,Caen,France
3 CHU Tours,Tours,France
4 CHU du Bocage
Conference
UEG Week 2015
Citation
United European Gastroenterology Journal; 2015: 2 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing